Anúncio
Anúncio
ADIL
Adial Pharmaceuticals, Inc
0.24
USDPatrocinado
+0.01
+3.64%
09 de jan., 15:41 UTC -5
Encerrado
Pós-Mercado
0.25
0.00
+1.65%
Relatórios de Lucros ADIL
Rácio de surpresa positiva
ADIL separação 13 de 25 últimas estimativas.
52%
Próximo Relatório
Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.08
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-77.14%
Adial Pharmaceuticals, Inc earnings per share and revenue
On 13 de nov. de 2025, ADIL reported earnings of -0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.14 USD, resulting in a 43.98% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an aumentar of 0.00% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Adial Pharmaceuticals, Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Adial Pharmaceuticals, Inc reported EPS of -$0.08, beating estimates by 43.98%, and revenue of $0.00, 0% as expectations.
How did the market react to Adial Pharmaceuticals, Inc's Q3 2025 earnings?
The stock price moved up 1.91%, changed from $0.32 before the earnings release to $0.33 the day after.
When is Adial Pharmaceuticals, Inc expected to report next?
The next earning report is scheduled for 02 de mar. de 2026.
What are the forecasts for Adial Pharmaceuticals, Inc's next earnings report?
Based on 5
analistas, Adial Pharmaceuticals, Inc is expected to report EPS of -$0.08 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio